丙型肝炎患者纤维化的无创预测 - Suppr

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

作者信息

Thabut Dominique, Simon Marion, Myers Robert P, Messous Djamila, Thibault Vincent, Imbert-Bismut Françoise, Poynard Thierry

出版信息

Hepatology. 2003 May;37(5):1220-1; author reply 1221. doi: 10.1053/jhep.2003.50109.

DOI:10.1053/jhep.2003.50109

PMID:12717403

Abstract

摘要

相似文献

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

Hepatology. 2003 May;37(5):1220-1; author reply 1221. doi: 10.1053/jhep.2003.50109.

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.

Hepatology. 2003 May;37(5):1222; author reply 1222-3. doi: 10.1053/jhep.2003.50159.

External validation of FibroIndex.

Hepatology. 2007 Jul;46(1):280-1; author reply 281-2. doi: 10.1002/hep.21717.

External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.

Am J Gastroenterol. 2005 Apr;100(4):868-73. doi: 10.1111/j.1572-0241.2005.40881.x.

Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.

J Viral Hepat. 2006 Oct;13(10):643-51. doi: 10.1111/j.1365-2893.2006.00730.x.

Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.

Hepatology. 2006 Feb;43(2):378-9; author reply 379. doi: 10.1002/hep.21037.

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?

Curr Opin HIV AIDS. 2010 Nov;5(6):517-23. doi: 10.1097/COH.0b013e32833e3ee6.

Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.

J Viral Hepat. 2006 Oct;13(10):652-8. doi: 10.1111/j.1365-2893.2006.00743.x.

Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

J Viral Hepat. 2008 Mar;15(3):212-8. doi: 10.1111/j.1365-2893.2007.00932.x. Epub 2007 Dec 28.

Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.

Int J Clin Pract. 2007 Mar;61(3):438-43. doi: 10.1111/j.1742-1241.2006.00912.x.

引用本文的文献

Clinical Utility of Biomarkers of Liver Fibrosis.

Gastroenterol Hepatol (N Y). 2006 Jan;2(1):48-57.

Non-invasive serum fibrosis markers: A study in chronic hepatitis.

Bioimpacts. 2015;5(1):17-23. doi: 10.15171/bi.2015.05. Epub 2015 Feb 22.

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B.

Clin Mol Hepatol. 2014 Dec;20(4):347-54. doi: 10.3350/cmh.2014.20.4.347. Epub 2014 Dec 24.

Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C.

Indian J Med Res. 2014 Jul;140(1):123-9.

Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

AJR Am J Roentgenol. 2013 Dec;201(6):1204-10. doi: 10.2214/AJR.12.10039.

A lower serum gamma-glutamyltransferase level does not predict a sustained virological response in patients with chronic hepatitis C genotype 1.

Gut Liver. 2013 Jan;7(1):74-81. doi: 10.5009/gnl.2013.7.1.74. Epub 2012 Nov 13.

Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.

Hepat Mon. 2012 Mar;12(3):177-84. doi: 10.5812/hepatmon.853. Epub 2012 Mar 28.

A comparative study of non-invasive methods for fibrosis assessment in chronic HCV infection.

Hepat Mon. 2010 Spring;10(2):88-94. Epub 2010 Jun 1.

"Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.

World J Gastroenterol. 2011 Nov 7;17(41):4607-13. doi: 10.3748/wjg.v17.i41.4607.

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Dig Dis Sci. 2011 Oct;56(10):3038-44. doi: 10.1007/s10620-011-1710-2. Epub 2011 Apr 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

作者信息

Thabut Dominique, Simon Marion, Myers Robert P, Messous Djamila, Thibault Vincent, Imbert-Bismut Françoise, Poynard Thierry

出版信息

Hepatology. 2003 May;37(5):1220-1; author reply 1221. doi: 10.1053/jhep.2003.50109.

DOI:10.1053/jhep.2003.50109

PMID:12717403

Abstract

摘要

相似文献

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

Hepatology. 2003 May;37(5):1220-1; author reply 1221. doi: 10.1053/jhep.2003.50109.

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.

Hepatology. 2003 May;37(5):1222; author reply 1222-3. doi: 10.1053/jhep.2003.50159.

External validation of FibroIndex.

Hepatology. 2007 Jul;46(1):280-1; author reply 281-2. doi: 10.1002/hep.21717.

External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.

Am J Gastroenterol. 2005 Apr;100(4):868-73. doi: 10.1111/j.1572-0241.2005.40881.x.

Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.

J Viral Hepat. 2006 Oct;13(10):643-51. doi: 10.1111/j.1365-2893.2006.00730.x.

Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.

Hepatology. 2006 Feb;43(2):378-9; author reply 379. doi: 10.1002/hep.21037.

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?

Curr Opin HIV AIDS. 2010 Nov;5(6):517-23. doi: 10.1097/COH.0b013e32833e3ee6.

Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.

J Viral Hepat. 2006 Oct;13(10):652-8. doi: 10.1111/j.1365-2893.2006.00743.x.

Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

J Viral Hepat. 2008 Mar;15(3):212-8. doi: 10.1111/j.1365-2893.2007.00932.x. Epub 2007 Dec 28.

Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.

Int J Clin Pract. 2007 Mar;61(3):438-43. doi: 10.1111/j.1742-1241.2006.00912.x.

引用本文的文献

Clinical Utility of Biomarkers of Liver Fibrosis.

Gastroenterol Hepatol (N Y). 2006 Jan;2(1):48-57.

Non-invasive serum fibrosis markers: A study in chronic hepatitis.

Bioimpacts. 2015;5(1):17-23. doi: 10.15171/bi.2015.05. Epub 2015 Feb 22.

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B.

Clin Mol Hepatol. 2014 Dec;20(4):347-54. doi: 10.3350/cmh.2014.20.4.347. Epub 2014 Dec 24.

Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C.

Indian J Med Res. 2014 Jul;140(1):123-9.

Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

AJR Am J Roentgenol. 2013 Dec;201(6):1204-10. doi: 10.2214/AJR.12.10039.

A lower serum gamma-glutamyltransferase level does not predict a sustained virological response in patients with chronic hepatitis C genotype 1.

Gut Liver. 2013 Jan;7(1):74-81. doi: 10.5009/gnl.2013.7.1.74. Epub 2012 Nov 13.

Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.

Hepat Mon. 2012 Mar;12(3):177-84. doi: 10.5812/hepatmon.853. Epub 2012 Mar 28.

A comparative study of non-invasive methods for fibrosis assessment in chronic HCV infection.

Hepat Mon. 2010 Spring;10(2):88-94. Epub 2010 Jun 1.

"Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.

World J Gastroenterol. 2011 Nov 7;17(41):4607-13. doi: 10.3748/wjg.v17.i41.4607.

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Dig Dis Sci. 2011 Oct;56(10):3038-44. doi: 10.1007/s10620-011-1710-2. Epub 2011 Apr 28.

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Noninvasive prediction of fibrosis in patients with chronic hepatitis C.

作者信息

出版信息

相似文献

引用本文的文献